Avidity Biosciences Inc
RNA
Get informed when a big investor buys or sells
+ FollowMarket Cap$131.2M
Close$
$-7.61
193.2% downside
Current Fair Value
193.2% downsideOvervalued by 193.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $131.20 Million |
|---|---|
| Enterprise Value | $69.28 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.48 |
| Beta | 0.37 |
| Outstanding Shares | 17,106,000 |
Return
| Return on Equity | -208.95% |
|---|---|
| Return on Assets | -159.84% |
| Return on Invested Capital | -181.30% |
Valuation & Multiples
| P/E Ratio | -1.99 |
|---|---|
| PEG | 2.29 |
| Price to Sales | 4.08 |
| Price to Book Ratio | 0.68 |
| Enterprise Value to Revenue | 1.93 |
| Enterprise Value to EBIT | -0.15 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-1.16
Average shareholder expectationRevenue Estimate
$666,667
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.87
Average shareholder expectationRevenue Estimate
$15.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 1309.27% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.42%▼ 84.17% |
|---|---|
| Total Invested | $594,208▼ 99.69% |
| Investors Holding | 9▼ 150.00% |
ESG Score
No data